+44 (0)203 011 5574 info@orthocg.com

WATERLOO, ON, Feb. 21, 2019 /PRNewswire/ – Intellijoint Surgical®, a Canadian-held company developing and commercializing smart navigation for total joint replacements, is pleased to announce the appointment of Michael Alexiades, MD, to its Scientific Advisory Board (SAB). Dr. Alexiades is an orthopaedic surgeon at Hospital for Special Surgery (HSS) in New York City – the number one American hospital for orthopedics nine years in a row ranked by the US News & World Report. Dr. Alexiades will play an active role in clinical research and surgeon education while guiding the development of an expanded product portfolio bringing Intellijoint Surgical’s core technology to more surgical applications.

“Intellijoint Surgical is a true innovator in orthopaedic navigation,” commented Dr. Alexiades following his appointment. “As a high volume orthopedic surgeon, their flagship product – Intellijoint HIP® – enhances my accuracy during total hip arthroplasty (THA). It doesn’t slow me down and it is cost-effective for our hospital. I am excited to join the advisory team to further develop this technology and prove the benefits it has for patients.”

Dr. Alexiades specializes in hip, knee, shoulder and elbow surgery including arthroscopic surgery, joint-sparing surgery and total joint replacement. He is a trailblazer in the mini-anterior approach to THA and an early adopter of the partial knee replacement. Dr. Alexiades has been in practice for 29 years, all of which have been at HSS. In the last two years, Dr. Alexiades has completed hundreds of THAs using Intellijoint HIP to deliver the best possible outcomes for his patients.

“Dr. Alexiades was an essential team member in the development of Intellijoint HIP for the anterior approach,” explained Armen Bakirtzian, CEO & co-founder of Intellijoint Surgical. “His experience, knowledge and keen interest in developing technology to improve total joint replacement outcomes is an invaluable asset and I am so happy he is expanding his role by joining our SAB.”

Outside his clinical work, Dr. Alexiades is active in New York’s Finest Foundation, chairs the NYPD Article II Medical Board and is Chief Surgeon for the NY State Troopers Association. He is passionate about the education and training of residents and fellows, and is an examiner for the American Board of Orthopedic Surgery, with responsibility for the education and certification of orthopedic surgeons.

Dr. Alexiades joins an esteemed group of orthopaedic surgeons on Intellijoint Surgical’s SAB: Chairman, Dr. Allan Gross at Mount Sinai Hospital (Toronto, Ont.), and members: Dr. Wayne Paprosky at Rush University Medical Center (Chicago, Ill.); Dr. Michael Bradley at South County Hospital (South Kingstown, R.I.); and Dr. Ran Schwarzkopf at NYU Langone’s Hospital for Joint Diseases (New York, N.Y.).

About Intellijoint Surgical:

Intellijoint Surgical® develops and commercializes surgical navigation solutions. Intellijoint’s flagship product, Intellijoint HIP® provides surgeons with real-time, intraoperative measurements to ensure proper size selection and positioning of orthopaedic implants during total hip replacements. Intellijoint is committed to improving patients’ lives by providing every surgeon with effective, easy-to-use technology.

Intellijoint Surgical is the recipient of the North American Frost & Sullivan Enabling Technology Leadership Award, the Futurpreneur Shopify True Grit Award and the Growing Strong Futurpreneur Award.

SOURCE Intellijoint Surgical Inc., PRNewswire, Feb 21, 2019

Related Links

https://www.intellijointsurgical.com/